HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An issue of dependence: implications from the Aliskiren in the Evaluation of Proteinuria in Diabetes (AVOID) trial.

AuthorsDaniel M Riche, Deborah S Minor, Amber S Holdiness, Honey E East
JournalJournal of clinical hypertension (Greenwich, Conn.) (J Clin Hypertens (Greenwich)) Vol. 11 Issue 2 Pg. 89-93 (Feb 2009) ISSN: 1751-7176 [Electronic] United States
PMID19222674 (Publication Type: Comparative Study, Journal Article, Review)
Chemical References
  • Amides
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Fumarates
  • aliskiren
Topics
  • Amides (administration & dosage)
  • Angiotensin II Type 1 Receptor Blockers (administration & dosage)
  • Angiotensin-Converting Enzyme Inhibitors (administration & dosage)
  • Antihypertensive Agents (administration & dosage)
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 (complications)
  • Diabetic Nephropathies (complications, prevention & control)
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Fumarates (administration & dosage)
  • Humans
  • Hypertension (complications, drug therapy)
  • Proteinuria (etiology, prevention & control)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: